Literature DB >> 3674089

Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.

R S Woodward1, G Medoff, M D Smith, J L Gray.   

Abstract

Strictly enforced formulary restrictions for aminoglycosides, cephalosporins, and a vancomycin group generated combined savings of $2.61 (p less than 0.0046) per antibiotic day and $34,597 (p less than 0.0003) per month. Even after some cost increases (not significant) in new and other antibiotics, the program saved $1.33 (p less than 0.0175) per antibiotic day and $24,620 (p less than 0.0311) per month for all antibiotics. The pharmacy's 1985 average cost per antibiotic day and its monthly expenditures were $18.45 and $199,003, respectively. In the months following the formulary restrictions, no significant detrimental changes occurred in hospital length of stay or mortality. A retrospective analysis of 322 patients with bacteremia treated before and after the onset of the controls revealed that antibiotics were more appropriately used afterwards.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3674089     DOI: 10.1016/0002-9343(87)90636-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

1.  Monitoring of antimicrobial therapy by an integrated computer program.

Authors:  S Grau; J Monterde; A Carmona; L Drobnic; E Salas; M Marín; D Campany; J Mateu
Journal:  Pharm World Sci       Date:  1999-08

2.  Antimicrobial utilization and bacterial resistance at three different hospitals.

Authors:  V Vlahović-Palcevski; M Morović; G Palcevski; L Betica-Radić
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  The effects of acquisition cost and budget-based compensation on the attitudes of pharmacy directors toward the adoption of a cost-effective new drug.

Authors:  M Kolassa; M C Smith; B F Banahan; D D Garner; W F Shughart
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

4.  Do family physicians know the costs of medical care? Survey in British Columbia.

Authors:  G Michael Allan; Grant D Innes
Journal:  Can Fam Physician       Date:  2004-02       Impact factor: 3.275

5.  Drug cost containment at a large teaching hospital.

Authors:  P I Pillans; I Conry; B E Gie
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

Review 6.  Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Authors:  L L Ioannides-Demos; G M Eckert; A J McLean
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

7.  A review of limited lists and formularies: are they cost-effective?

Authors:  M J Pearce; E J Begg
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

8.  Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria.

Authors:  E Raineri; L Crema; S Dal Zoppo; A Acquarolo; A Pan; G Carnevale; F Albertario; A Candiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

Review 9.  Antimicrobial stewardship programs in health care systems.

Authors:  Conan MacDougall; Ron E Polk
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

10.  Use of perioperative antibiotic prophylaxis in selected surgical procedures--results of a survey in 889 surgical departments in German hospitals.

Authors:  I Kappstein; F D Daschner
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.